|
Presidential Fireside Chat: ISPOR Initiatives in Communication and Outreach
Peter Neumann ScD, ISPOR 2005-2006 President & Tufts University School of Medicine, Boston, MA, USA
In my incoming Presidential address last May, I outlined
three areas that I believe are critical for ISPOR's continued
success: 1) increasing our efforts to “internationalize” our
society; 2) striving for excellence in all of our activities and
monitoring our progress; and 3) expanding our outreach and
communication efforts. In my previous two fireside chats, (ISPOR
CONNECTIONS, September/October, 2005 and November/December
2005), I focused on the first two themes. Here I turn to the
third: communication and outreach.
Communication
I have long believed that we can do more to promote the good
work of ISPOR. Our annual meetings/congresses and publications
offer ideal vehicles. Clinical meetings, such as the American
Society of Clinical Oncology (ASCO), have become tremendous
generators of news. In some ways that reflects their size and
medical focus. However, it also reflects a deliberate and
increasingly sophisticated attempt to engage the media.
Furthermore, it signals a strong sense from these organizations
that their work warrants broad exposure to diverse and lay
audiences. I believe that we can learn from these efforts. In
similar fashion, I believe that we can learn from the growing
number of medical and health policy journals, from The New
England Journal of Medicine to Health Affairs, which maintain
strong communications and media-relations capabilities. There
are a number of benefits that would likely come from expanding
our communications activities. The first is that it would help
us translate our research into concrete policies - and help move
health systems forward so that decisions better reflect evidence
of value. Our work in pharmacoeconomics and outcomes research
should resonate with varied audiences, including payers,
physicians, patients, and the media.
The second likely benefit is an improvement in our own work.
The practice of communicating well -- to scientific audiences
and to audiences unschooled in our methods - will help us shape
and focus our analyses. Third, it should also produce
collateral benefits. Greater visibility will help us attract new
members and strengthen ties with existing ones.
To be sure, expanding communications presents challenges.
Some of our work is technical in nature and not easily
translated. Some of our studies are purely methodological.
Moreover, communications requires resources. Still, I believe we
should move forward energetically. We should not simply
communicate within our own field, but more aggressively seek to
translate our work for broader consumption. We should redouble
efforts to invite the press to the annual meetings (only small
handfull attend our annual meetings today). Authors of articles
and presenters at meetings should think harder about translating
their work for non-experts. Many of our studies are applied
analyses with potentially broad appeal. Even some methodological
studies may find audiences that surprise us. The Wall Street
Journal recently featured a front-page story on the National
Institute of Clinical Excellence that discussed the concept of
costs per QALY at some length. I am pleased to say that
we have begun to make strides in these areas. For the 2005
International Annual Meeting, a “Public Awareness” initiative
was implemented. Reviewers of abstracts now indicate whether the
results of a study will contribute to the health care
improvement of society and whether the public should be made
aware of the analysis. In the future we will use this
information to identify and motivate abstract authors to prepare
a press release for their study. ISPOR and our journal, Value
in Health, have begun issuing press releases on a regular basis.
They can be found at ISPOR website,
www.ispor.org/pressrelease/index.asp. In the past year,
communications has also become a higher priority for ISPOR
staff, with Daniel Klim assuming a greater role in this area.
The ISPOR Communications Task Force, led by John Hornberger and
Mark Nuijten, recently reported on ways to bridge the
communications gap between the health outcomes community and
health care decision makers.
The Task Force has worked to explore what is known about
effective communications of outcomes research findings, to
identify gaps, and to propose solutions for ISPOR.
Outreach One aspect of outreach involves partnering with other
associations. In principle, partnering is a good idea and offers
many possible benefits for ISPOR. It can enrich our own
experiences and help us spread the word about the value of our
work. It can also lead to new interactions, new contacts, and
new members.
However, partnering needs to be done strategically. With whom
should we partner? One possibility is to collaborate with an
organization focused on methods of outcomes research. We might
co-sponsor a methodological workshop, for example. Another is to
partner with a medical association. We might offer a slate of
courses at major clinical meetings, for example.
Another aspect of outreach is to reach out more aggressively to
medical device and biotechnology companies. We now have active
ISPOR Medical Device and Diagnostics Councils for North America,
Europe, and Asia-Pacific, and we will soon launch a new council
devoted to the biotechnology community.
A final and perhaps most important aspect of outreach involve
reaching out to public and private payers who can benefit from
the work. This is a longstanding priority for our society. ISPOR
has undertaken a number of initiatives aimed at having a “seat
at the table.” A prime example is the U.S. Medicare program's
recently released draft guidance on “Coverage with Evidence
Development.” ISPOR was one of 65 organizations to provide
comments on the draft guidance. The Task Force on Real World
Data helped to coordinate and draft the remarks.
In the future, we look forward to expanding on all of these
efforts. To achieve success we need commitment not only from
ISPOR staff and leadership and from Value in Health, but also
from our members. ISPOR's stated mission is to “translate
pharmacoeconomics and outcomes research into practice to ensure
that society allocates scarce health care resources wisely,
fairly, and efficiently.” Good communications and outreach are
vital to our success. |